United States Dendritic Cell Cancer Vaccine Market Report 2016

United States Dendritic Cell Cancer Vaccine Market Report 2016

1 Dendritic Cell Cancer Vaccine Overview

1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine

1.2 Classification of Dendritic Cell Cancer Vaccine

1.2.11 CreaVax

1.2.12 Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK)

1.2.13 Provenge

1.3 Application of Dendritic Cell Cancer Vaccine

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dendritic Cell Cancer Vaccine (2011-2021)

1.4.1 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)

1.4.2 United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)

2 United States Dendritic Cell Cancer Vaccine Competition by Manufacturers

2.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Dendritic Cell Cancer Vaccine Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Dendritic Cell Cancer Vaccine Average Price by Manufactures (2015 and 2016)

2.4 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends

2.4.1 Dendritic Cell Cancer Vaccine Market Concentration Rate

2.4.2 Dendritic Cell Cancer Vaccine Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Dendritic Cell Cancer Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2011-2016)

3.2 United States Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)

3.3 United States Dendritic Cell Cancer Vaccine Price by Type (2011-2016)

3.4 United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Type (2011-2016)

4 United States Dendritic Cell Cancer Vaccine Sales (Volume) by Application (2011-2016)

4.1 United States Dendritic Cell Cancer Vaccine Sales and Market Share by Application (2011-2016)

4.2 United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Dendritic Cell Cancer Vaccine Manufacturers Profiles/Analysis

5.1 3M Company

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Activartis

5.2.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Batavia Bioservices

5.3.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Creagene

5.4.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Dendreon

5.5.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Merck

5.6.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Northwest Biotherapeutics

5.7.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Glaxo Smith Kline

5.8.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 ImmunoCellular Therapeutics

5.9.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Tella Incorporation

5.10.2 Dendritic Cell Cancer Vaccine Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

…

6 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis

6.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Dendritic Cell Cancer Vaccine Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Dendritic Cell Cancer Vaccine Market Forecast (2016-2021)

10.1 United States Dendritic Cell Cancer Vaccine Sales, Revenue Forecast (2016-2021)

10.2 United States Dendritic Cell Cancer Vaccine Sales Forecast by Type (2016-2021)

10.3 United States Dendritic Cell Cancer Vaccine Sales Forecast by Application (2016-2021)

10.4 Dendritic Cell Cancer Vaccine Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Dendritic Cell Cancer Vaccine

Table Classification of Dendritic Cell Cancer Vaccine

Figure United States Sales Market Share of Dendritic Cell Cancer Vaccine by Type in 2015

Figure CreaVax Picture

Figure Dendritic Cell Activated Cytokine Induced Killer Cells (DC-CIK) Picture

Figure Provenge Picture

Table Application of Dendritic Cell Cancer Vaccine

Figure United States Sales Market Share of Dendritic Cell Cancer Vaccine by Application in 2015

Figure United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2011-2021)

Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate (2011-2021)

Table United States Dendritic Cell Cancer Vaccine Sales of Key Manufacturers (2015 and 2016)

Table United States Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers

Figure 2016 Dendritic Cell Cancer Vaccine Sales Share by Manufacturers

Table United States Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2015 and 2016)

Table United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers

Table 2016 United States Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers

Table United States Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Dendritic Cell Cancer Vaccine Average Price of Key Manufacturers in 2015

Figure Dendritic Cell Cancer Vaccine Market Share of Top 3 Manufacturers

Figure Dendritic Cell Cancer Vaccine Market Share of Top 5 Manufacturers

Table United States Dendritic Cell Cancer Vaccine Sales by Type (2011-2016)

Table United States Dendritic Cell Cancer Vaccine Sales Share by Type (2011-2016)

Figure United States Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2015

Table United States Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2011-2016)

Table United States Dendritic Cell Cancer Vaccine Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Dendritic Cell Cancer Vaccine by Type (2011-2016)

Table United States Dendritic Cell Cancer Vaccine Price by Type (2011-2016)

Figure United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Type (2011-2016)

Table United States Dendritic Cell Cancer Vaccine Sales by Application (2011-2016)

Table United States Dendritic Cell Cancer Vaccine Sales Market Share by Application (2011-2016)

Figure United States Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2015

Table United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)

Figure United States Dendritic Cell Cancer Vaccine Sales Growth Rate by Application (2011-2016)

Table 3M Company Basic Information List

Table 3M Company Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Figure 3M Company Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Activartis Basic Information List

Table Activartis Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Activartis Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Batavia Bioservices Basic Information List

Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Creagene Basic Information List

Table Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Creagene Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Dendreon Basic Information List

Table Dendreon Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dendreon Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Northwest Biotherapeutics Basic Information List

Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Glaxo Smith Kline Basic Information List

Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table ImmunoCellular Therapeutics Basic Information List

Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Tella Incorporation Basic Information List

Table Tella Incorporation Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tella Incorporation Dendritic Cell Cancer Vaccine Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine

Figure Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine

Figure Dendritic Cell Cancer Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Dendritic Cell Cancer Vaccine Major Manufacturers in 2015

Table Major Buyers of Dendritic Cell Cancer Vaccine

Table Distributors/Traders List

Figure United States Dendritic Cell Cancer Vaccine Production and Growth Rate Forecast (2016-2021)

Figure United States Dendritic Cell Cancer Vaccine Revenue and Growth Rate Forecast (2016-2021)

Table United States Dendritic Cell Cancer Vaccine Production Forecast by Type (2016-2021)

Table United States Dendritic Cell Cancer Vaccine Consumption Forecast by Application (2016-2021)